| Experiment name | Clinical attributes |
| Chen02_Adenoma_HK69 | Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*) |
| Chen02_HCC_HBV_HK66_T2 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*) |
| Chen02_HCC_HK2 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Invasive liver tumor (Liver cancer) |
| Chen02_Hep3B_cells | Cancer and cell line (Liver cancer), Liver tissue, cancer or cell line (Liver cancer*), Cell line (Liver cancer), Liver cancer cell line (Liver cancer) |
| Perou00_BC114B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
| Ross00_MDA_MB_435_CL5011_BREAST | Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
| Ross00_MDA_N_CL5012_BREAST | Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
| Ross01_BT474_Stanford |
| Sorlie01_BC_HBC3 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
| Whitfield02_0_1hr_Hela_Double_Thymidine | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |
| Whitfield02_11_hr_Hela_Double_Thymidine_exp2 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |
| Whitfield02_36h_Thy_Noc_Exp4 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |
| Whitfield02_44_hr_Hela_Double_Thymidine_exp2 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |